Subscribe to our email newsletter
Be kept in the loop about our latest news on pancreatic cancer, the charity and our supporters.
Your support today will mean we are here for patients tomorrow.Donate
We have a range of free healthcare resources specifically tailored for healthcare professionals including information on our e-learning modules, published reports, our patient information publications and awareness materials available to order.
Covid-19 update: click here for updated NICE guidelines
If you have a patient with suspected pancreatic cancer, their diagnosis is likely to be affected by Covid-19. Urgent and routine endoscopies are being postponed or cancelled in many trusts across the country so you may wish to consider other diagnostic options for the disease.
Patients with pancreatic cancer are at an increased risk of contracting Covid-19 and experiencing complications as a result of the disease. Although NHS England are asking hospital trusts to continue to prioritise cancer care, on a local level this has not always been possible. Furthermore, for some patients, adjusting or postponing their current treatment regime may be the safest way of managing their condition.
The National Institute for Health and Care Excellence (NICE) have produced a series of rapid guidelines for prioritising patient care during the Covid-19 outbreak. This includes advice on use of chemo and radiotherapy and is available here https://www.nice.org.uk/covid-19
Guidelines have also been updated to reflect changes in arranging planned care for patients during the pandemic recovery and beyond https://www.nice.org.uk/guidance/ng179
Pancreatic cancer is a rarer cancer and you may only see a patient with pancreatic cancer a few times over the course of your career. However, it is the fifth biggest cancer killer in the UK and is expected to rise.
You can find resources for you and your patient below, organised according to their stage in the patient journey.
Pancreatic cancer is a rarer cancer and you may only see a patient with pancreatic cancer a few times over the course of a career. However, pancreatic cancer is the fifth biggest cancer killer in the UK and is expected to rise. As survival improves in other cancers, pancreatic cancer receives just 3% of research funding and has no routine screening test.
The information provided in this site, or through links to other websites, is not a substitute for medical or professional care and should not be relied upon as such. Read our disclaimer.